ReferencesBasic Mechanisms of Thrombosis and Hemostasis1.
Libby P: The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008; 263:517.2.
Mackman N: Triggers, targets and treatments of thrombosis. Nature 2008; 451:914.3.
Emmerich J, Meyer G, Decousus H, et al: Role of fibrinolysis and interventional therapy for acute venous thromboembolism. Thromb Haemost 2006; 96:251.4.
Marcus AJ, Broekman MJ, Drosopoulos JH, et al: Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 2005; 31:234.5.
Li JP, Vlodavsky I: Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb Haemost 2009; 102:823.6.
Lwaleed BA, Bass PS: Tissue factor pathway inhibitor: Structure, biology and involvement in disease. J Pathol 2006; 208:327.7.
Tobu M, Ma Q, Iqbal O, et al: Comparative tissue factor pathway inhibitor release potential of heparins. Clin Appl Thromb Hemost 2005; 11:37.8.
Esmon CT: Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 2006; 32:49.9.
Esmon CT: Structure and functions of the endothelial cell protein ….